Search research articles
Contact Us
Filters
Showing results (171-180 of 186) with videos related to
Page
of 19
Sort By:
Frontiers in Cellular and Infection Microbiology
|
February 12, 2026
Real-world usage, effectiveness, and microbiological features of ceftazidime-avibactam in clinical practice in China
Xiaohua Qin, Tianxin Xiang, Xiaoju Zhang, et al.
The Journal of Antimicrobial Chemotherapy
|
July 3, 2021
Establishment of epidemiological cut-off values for cefoselis, a new fourth-generation cephalosporin, against Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Proteus mirabilis and Pseudomonas aeruginosa
Xue Li, Peiyao Jia, Ying Zhu, et al.
The Journal of Antimicrobial Chemotherapy
|
October 15, 2020
Determination of norvancomycin epidemiological cut-off values (ECOFFs) for Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus hominis
Qiwen Yang, Xue Li, Peiyao Jia, et al.
Jac-Antimicrobial Resistance
|
July 29, 2025
Aztreonam-avibactam for the treatment of serious infections caused by metallo-β-lactamase-producing Gram-negative pathogens: a Phase 3 randomized trial (ASSEMBLE)
George L Daikos, José Miguel Cisneros, Yehuda Carmeli, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
|
March 31, 2026
The 2025 guidance on the surveillance and control of Candida infections: Recommendations from the China invasive fungal surveillance net (CHIF-NET) study group
Meng Xiao, Li Zhang, He Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 8, 2023
International Epidemiology of Carbapenemase-Producing Escherichia coli
Angelique E Boutzoukas, Lauren Komarow, Liang Chen, et al.
The Lancet. Infectious Diseases
|
October 10, 2024
Aztreonam-avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial
Yehuda Carmeli, José Miguel Cisneros, Mical Paul, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
|
March 3, 2023
Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli
Mei Zeng, Jun Xia, Zhiyong Zong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 28, 2020
Diagnosis and Management of Intraabdominal Infection: Guidelines by the Chinese Society of Surgical Infection and Intensive Care and the Chinese College of Gastrointestinal Fistula Surgeons
Xiuwen Wu, Jie Wu, Peige Wang, et al.
The Lancet. Infectious Diseases
|
March 11, 2020
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study
David van Duin, Cesar A Arias, Lauren Komarow, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 186) with videos related to
Sort By:
Page
of 19
Frontiers in Cellular and Infection Microbiology
|
February 12, 2026
Real-world usage, effectiveness, and microbiological features of ceftazidime-avibactam in clinical practice in China
Xiaohua Qin, Tianxin Xiang, Xiaoju Zhang, et al.
The Journal of Antimicrobial Chemotherapy
|
July 3, 2021
Establishment of epidemiological cut-off values for cefoselis, a new fourth-generation cephalosporin, against Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Proteus mirabilis and Pseudomonas aeruginosa
Xue Li, Peiyao Jia, Ying Zhu, et al.
The Journal of Antimicrobial Chemotherapy
|
October 15, 2020
Determination of norvancomycin epidemiological cut-off values (ECOFFs) for Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus hominis
Qiwen Yang, Xue Li, Peiyao Jia, et al.
Jac-Antimicrobial Resistance
|
July 29, 2025
Aztreonam-avibactam for the treatment of serious infections caused by metallo-β-lactamase-producing Gram-negative pathogens: a Phase 3 randomized trial (ASSEMBLE)
George L Daikos, José Miguel Cisneros, Yehuda Carmeli, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
|
March 31, 2026
The 2025 guidance on the surveillance and control of Candida infections: Recommendations from the China invasive fungal surveillance net (CHIF-NET) study group
Meng Xiao, Li Zhang, He Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 8, 2023
International Epidemiology of Carbapenemase-Producing Escherichia coli
Angelique E Boutzoukas, Lauren Komarow, Liang Chen, et al.
The Lancet. Infectious Diseases
|
October 10, 2024
Aztreonam-avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial
Yehuda Carmeli, José Miguel Cisneros, Mical Paul, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
|
March 3, 2023
Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli
Mei Zeng, Jun Xia, Zhiyong Zong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 28, 2020
Diagnosis and Management of Intraabdominal Infection: Guidelines by the Chinese Society of Surgical Infection and Intensive Care and the Chinese College of Gastrointestinal Fistula Surgeons
Xiuwen Wu, Jie Wu, Peige Wang, et al.
The Lancet. Infectious Diseases
|
March 11, 2020
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study
David van Duin, Cesar A Arias, Lauren Komarow, et al.
Page
of 19